Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H14N2O |
| Molecular Weight | 178.231 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=CC(C)=C1NC(=O)CN
InChI
InChIKey=IXYVBZOSGGJWCW-UHFFFAOYSA-N
InChI=1S/C10H14N2O/c1-7-4-3-5-8(2)10(7)12-9(13)6-11/h3-5H,6,11H2,1-2H3,(H,12,13)
| Molecular Formula | C10H14N2O |
| Molecular Weight | 178.231 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Quantitative analysis of lignocaine and metabolites in equine urine and plasma by liquid chromatography-tandem mass spectrometry. | 2010-07-15 |
|
| [Determination of lidocaine and its metabolites in human plasma by liquid chromatography in combination with tandem mass spectrometry]. | 2010-07 |
|
| Serum concentrations of lidocaine and its metabolites after prolonged infusion in healthy horses. | 2008-06 |
|
| Effect of erythromycin and rifampicin on monoethylglycinexylidide test. | 2008-03 |
|
| Determination of lidocaine and its two N-desethylated metabolites in dog and horse plasma by high-performance liquid chromatography combined with electrospray ionization tandem mass spectrometry. | 2007-06-01 |
|
| Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis. | 2006-12 |
|
| Thrombosis as a conformational disease. | 2005-02 |
|
| Effect of lidocaine on the minimum alveolar concentration of isoflurane in dogs. | 2004-10 |
|
| Propofol does not inhibit lidocaine metabolism during epidural anesthesia. | 2004-10 |
|
| Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function. | 2004-01 |
|
| Utility of nonaqueous capillary electrophoresis for the determination of lidocaine and its metabolites in human plasma: a comparison of ultraviolet and mass spectrometric detection. | 2004 |
|
| Free lidocaine concentrations during continuous epidural anesthesia in geriatric patients. | 2003-05-29 |
|
| Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function. | 2003-01 |
|
| Chromatographic determination of free lidocaine and its active metabolites in plasma from patients under epidural anesthesia. | 2002-11 |
|
| Involvement of liver carboxylesterases in the in vitro metabolism of lidocaine. | 2002-06 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:59:21 GMT 2025
by
admin
on
Mon Mar 31 22:59:21 GMT 2025
|
| Record UNII |
D2D932W316
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
D2D932W316
Created by
admin on Mon Mar 31 22:59:21 GMT 2025 , Edited by admin on Mon Mar 31 22:59:21 GMT 2025
|
PRIMARY | |||
|
18865-38-8
Created by
admin on Mon Mar 31 22:59:21 GMT 2025 , Edited by admin on Mon Mar 31 22:59:21 GMT 2025
|
PRIMARY | |||
|
357241
Created by
admin on Mon Mar 31 22:59:21 GMT 2025 , Edited by admin on Mon Mar 31 22:59:21 GMT 2025
|
PRIMARY | |||
|
87833
Created by
admin on Mon Mar 31 22:59:21 GMT 2025 , Edited by admin on Mon Mar 31 22:59:21 GMT 2025
|
PRIMARY | |||
|
DTXSID40876064
Created by
admin on Mon Mar 31 22:59:21 GMT 2025 , Edited by admin on Mon Mar 31 22:59:21 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
BINDER->LIGAND |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE LESS ACTIVE |
PLASMA
|
